David Jin - Net Worth and Insider Trading

David Jin Net Worth

The estimated net worth of David Jin is at least $164,599 dollars as of 2024-05-14. David Jin is the CFO of Fortress Biotech Inc and owns about 93,522 shares of Fortress Biotech Inc (FBIO) stock worth over $164,599. Details can be seen in David Jin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Jin has not made any transactions after 2022-11-30 and currently still holds the listed stock(s).

Transaction Summary of David Jin

To

David Jin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Jin owns 2 companies in total, including Avenue Therapeutics Inc (ATXI) , and Fortress Biotech Inc (FBIO) .

Click here to see the complete history of David Jin’s form 4 insider trades.

Insider Ownership Summary of David Jin

Ticker Comapny Transaction Date Type of Owner
ATXI Avenue Therapeutics Inc 2022-05-11 Int. PEO & Int. PFO & and COO
FBIO Fortress Biotech Inc 2022-11-30 Chief Financial Officer

David Jin Latest Holdings Summary

David Jin currently owns a total of 1 stock. David Jin owns 93,522 shares of Fortress Biotech Inc (FBIO) as of November 30, 2022, with a value of $164,599.

Latest Holdings of David Jin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FBIO Fortress Biotech Inc 2022-11-30 93,522 1.76 164,599

Holding Weightings of David Jin


David Jin Form 4 Trading Tracker

According to the SEC Form 4 filings, David Jin has made a total of 1 transactions in Fortress Biotech Inc (FBIO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fortress Biotech Inc is the acquisition of 333 shares on November 30, 2022, which cost David Jin around $2,800.

Insider Trading History of David Jin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David Jin Trading Performance

GuruFocus tracks the stock performance after each of David Jin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Jin is 13.41%. GuruFocus also compares David Jin's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Jin within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David Jin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David Jin

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.95
Relative Return to S&P 500(%) 4.95

David Jin Ownership Network

Ownership Network List of David Jin

No Data

Ownership Network Relation of David Jin


David Jin Owned Company Details

What does Avenue Therapeutics Inc do?

Who are the key executives at Avenue Therapeutics Inc?

David Jin is the Int. PEO & Int. PFO & and COO of Avenue Therapeutics Inc. Other key executives at Avenue Therapeutics Inc include 10 percent owner Fortress Biotech, Inc. , 10 percent owner Invagen Pharmaceuticals, Inc. , and Chief Executive Officer Alexandra Maclean .

Avenue Therapeutics Inc (ATXI) Insider Trades Summary

Over the past 18 months, David Jin made no insider transaction in Avenue Therapeutics Inc (ATXI). Other recent insider transactions involving Avenue Therapeutics Inc (ATXI) include a net sale of 617,000 shares made by , a net purchase of 418,410 shares made by Fortress Biotech, Inc. , and a net purchase of 348,675 shares made by Rosenwald Lindsay A Md .

In summary, during the past 3 months, insiders sold 0 shares of Avenue Therapeutics Inc (ATXI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,227 shares of Avenue Therapeutics Inc (ATXI) were sold and 10,228 shares were bought by its insiders, resulting in a net purchase of 2,001 shares.

Avenue Therapeutics Inc (ATXI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Avenue Therapeutics Inc Insider Transactions

No Available Data

David Jin Mailing Address

Above is the net worth, insider trading, and ownership report for David Jin. You might contact David Jin via mailing address: C/o Avenue Therapeutics, Inc., 1140 Avenue Of The Americas, Floor 9, New York Ny 10036.

Discussions on David Jin

No discussions yet.